Teva Pharmaceutical Industries Aktie
WKN: 883035 / ISIN: US8816242098
28.08.2025 14:58:08
|
Teva Announces FDA Approval And U.S. Launch Of Generic Saxenda
(RTTNews) - Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), Thursday said that the U.S. Food and Drug Administration (FDA) has approved a generic version of Novo Nordisk's Saxenda, indicated for adults with obesity.
Teva also announced U.S. launch of the drug.
As of June 2025, Saxenda had annual sales of $165 million.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!